Table 1. Rating scales for assessing clinical added benefit/improvement used in France (HAS) and Germany (G-BA), from highest (top) to lowest (bottom) rating categories. Significant differences in the context of this research are any differences in ratings between HAS and G-BA that are 2 or more categories/steps from each other, such as Tivicay and Rukobia.
